About The Position

The Principal Reimbursement Analyst leads the development and execution of reimbursement and health economic strategies that support market access, funding, and adoption of Medtronic Pelvic Health therapies across Europe. The Pelvic Health business focuses on therapies for overactive bladder and fecal incontinence, including sacral nerve stimulation and implantable tibial neurostimulator technology. The role supports evidence generation, value positioning, Health Technology Assessment (HTA) submissions, and reimbursement pathways for innovative medical technologies, working with regional and global stakeholders. This is a remote role that may be based in the United Kingdom, France, Germany, Italy, or another appropriate Western European location. Expected travel is approximately 20% of working time across the region.

Requirements

  • Experience developing and executing reimbursement, market access, health economics, Health Technology Assessment (HTA), or healthcare funding strategies within the medical device or pharmaceutical industry.
  • Experience developing reimbursement submissions, funding applications, or market access strategies for healthcare technologies.
  • Experience conducting health economic analyses, outcomes research, or economic model development.
  • Knowledge of European reimbursement, healthcare funding, and Health Technology Assessment (HTA) systems.
  • Fluency in English.

Nice To Haves

  • Master's degree, Master of Public Health (MPH), Master of Public Policy (MPP), Master of Business Administration (MBA), Doctor of Philosophy (PhD), or Medical Doctor (MD).
  • Experience supporting medical device and implantable device therapies and/or diligence or submissions in reimbursement strategies for new technologies.
  • Additional European language proficiency, peer-reviewed publications, or experience developing multi-country reimbursement strategies within Europe.

Responsibilities

  • Lead reimbursement and market access strategies for Pelvic Health therapies across European markets.
  • Shape evidence-generation plans by providing reimbursement and health economics input into clinical study design, healthcare utilization measures, and patient-reported outcomes.
  • Develop health economic analyses, including cost-effectiveness, cost-utility, cost-of-illness, and budget impact models, to support reimbursement and funding submissions.
  • Create regional value dossiers, value propositions, and economic tools supporting Health Technology Assessment (HTA), Diagnosis-Related Group (DRG), and payer funding requirements.
  • Partner with marketing, clinical, pricing, government affairs, and market access teams to align evidence-generation and reimbursement priorities.
  • Define and communicate clinical and economic evidence to internal and external stakeholders through reimbursement submissions, scientific publications, and educational initiatives.
  • Monitor reimbursement and healthcare policy developments across Europe, identifying market access risks and opportunities that inform business strategy.

Benefits

  • Flexible benefits package
  • Competitive compensation plans
  • Short-term incentive through the Medtronic Incentive Plan (MIP)
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service